IL17A and Autoimmunity: Hence, DMF treatment caused a loss of the Tc17-dependent Th17 pathogenicity and conferred a stable “low IL-17” phenotype to Tc17 cells, suggesting a mechanism for amelioration of autoimmunity in CNS upon DMF treatment.